Edit search
Year 2 efficacy results of 2 randomized controlled clinical …
Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.
Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.
Article, Chapter
Authors: U. Chakravarthy
Publication: Ophthalmology, Volume:113, Issue:9
Published: Elsevier, 2006
ISSN: 0161-6420
  Full text availability for this item
Browse related articles
  Print copies at your library
  Request a copy of this item
Cite this item